Turner, Meghan T.
Geltzeiler, Mathew
Albergotti, W. Greer
Duvvuri, Umamaheswar
Ferris, Robert L.
Kim, Seungwon
Wang, Eric W.
Funding for this research was provided by:
T32 Grant (CA060397)
SPORE Grant (P50 CA097190)
Article History
Received: 19 May 2019
Accepted: 3 June 2019
First Online: 10 June 2019
Compliance with ethical standards
:
: Robert L. Ferris, MD, PhD has the following disclosures: Amgen (Advisory Board); Astra-Zeneca/MedImmune (Advisory Board, Clinical trial, Research Funding); Bristol-Myers Squibb (Advisory board, Clinical trial, Research funding); EMD Serono (Advisory Board); Benetic (Advisory Board); Lilly (Advisory Board); Merck (Advisory Board, Clinical trial); Pfizer (Advisory Board); VentiRx Pharmaceuticals (Research funding). Meghan T. Turner, Mathew Geltzeiler, MD, W. Greer Albergotti, MD, Umamaheswar Duvvuri, MD, PhD, Seungwon Kim, MD, Eric W. Wang, MD, declare that they have no conflicts of interest. The NSF provides excellent local flap reconstruction for lateral oropharyngectomy defects following TORS. This is the first description of a laterally-based, pedicled NSF design utilization for ICA coverage during transoral surgery. This required minimal additional surgical time and was effective in preventing acute or delayed ICA bleeding. Additionally, it postoperative healing. Although reported here only during TORS oropharyngectomy, it is intuitive that this technique also applies to transoral laser microsurgery.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study per institutional protocols.